Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lucid Diagnostics Inc
(NQ:
LUCD
)
0.8350
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lucid Diagnostics Inc
< Previous
1
2
Next >
PAVmed and Lucid Diagnostics Provide Strategic Business Update
January 17, 2023
From
PAVmed Inc.
Via
Business Wire
PAVmed and Lucid Diagnostics to Provide Strategic Business Update
January 11, 2023
From
PAVmed Inc.
Via
Business Wire
PAVmed Partners with Novosound on Ultrasound Imaging Technology
December 22, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
December 08, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform
December 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
December 01, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Provides Business Update and Third Quarter 2022 Financial Results
November 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results
November 14, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer
November 09, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022
November 02, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results
August 15, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio
August 11, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies
August 04, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics’ Laboratory Executes Four New Participating Provider Agreements
August 02, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022
August 01, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference
July 18, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
May 11, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
May 13, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022
April 25, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
May 09, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
March 29, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination
April 04, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
March 28, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference
March 30, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
March 24, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
March 23, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Appoints Shaun O’Neil as Chief Operating Officer
February 24, 2022
From
PAVmed Inc.
Via
Business Wire
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors
February 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
February 10, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.